Breast Cancer, Ovarian Cancer, Research and Clinical Trials

Faye Belvin: Living a healthy life, thanks to a phase I clinical trial

By Nicole Ferrara • July 5, 2022
Estimated reading time: 1 minute

Faye Belvin, a 58-year-old woman from Jacksonville, FL, was diagnosed and successfully treated for ovarian cancer in 2021 after having been treated for breast cancer in 2020. Her treatment included a phase I clinical trial at Mayo Clinic. Her story was highlighted by the American Association for Cancer Research Cancer Disparities Progress Report 2022. Read more of Faye's story here.

Learn more

Learn why cancer clinical trials are important.

Find a clinical trial and learn more about participating in clinical trials and research at Mayo Clinic.

American Association of Cancer Research Breast Cancer cancer clinical trials Cancer Disparities Progress Report 2022 Faye Belvin Ovarian Cancer Research and Clinical Trials
Subscribe
Request an Appointment
Find a Clinical Trial
Mayo Clinic researchers identify proteins linked to immunotherapy resistance in metastatic colorectal cancer

The team identified specific proteins — fibronectin and smooth muscle actin — associated with resistance to immunotherapy treatment in colorectal cancer tissues.

Smoldering multiple myeloma: What it is, how it progresses and the latest research

Drs. Vincent Rajkumar and Rafael Fonseca explain what smoldering multiple myeloma is and how treating it could potentially delay or prevent multiple myeloma.

Mayo Clinic discovers new role for protein to fight tumors

Researchers have discovered a new role that a protein known as NKG7 plays in regulating cell resistance and fighting tumors in certain types of cancer.